arrow
M

Mireia Morgades

Josep Carreras Leukaemia Research Institute
H指数:24
被引数:2,330

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA

慢性骨髓单核细胞白血病的IPSS-M评估

2026-08-030
OA
Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia

费城染色体阴性急性淋巴细胞白血病患者治疗分配中的遗传学及微小残留病

Blood
IF23.1
2026-05-060
PRE
Comprehensive genetic characterization of adult BCR :: ABL1 -negative B-ALL by optical genome mapping and targeted NGS

通过光学基因组图谱和靶向NGS对成人BCR::ABL1阴性B-ALL的全面遗传表征

2026-01-010
OA
Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy

大B细胞淋巴瘤患者接受CAR T细胞治疗时的患者选择与治疗结果随时间的变化

2025-09-300
PRE
Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials

在PETHEMA试验中治疗的成人T细胞急性淋巴细胞白血病患者的遗传进化和复发相关突变

2025-05-260
OA
Assessment of the IPSS-M in Chronic Myelomonocytic Leukemia

IPSS-M在慢性髓系单核细胞白血病中的评估

BLOOD
IF23.1
2024-11-050
PRE
Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials
2024-08-080
OAAI
Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis
2024-07-010
OAAI
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA (vol 12, 13057, 2022)
2024-03-280
OAAI
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response
2024-01-292
OAAI
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial
2023-08-104
OAAI
Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols
2023-01-010
OAAI
Genomics improves risk stratifi cation of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials
2022-11-036
OAAI
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA
2022-07-2911
OAAI
Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis
2020-05-142
OAAI
Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia
2019-09-1931
OAAI
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia

通过成人T细胞急性淋巴细胞白血病的深入遗传分析评估CDKN2A/ARF/CDKN2B基因缺失的频率和临床影响

2018-07-2421
OAAI